Connection

Robert Stuart to Leukemia, B-Cell

Back to Details
This is a "connection" page, showing publications Robert Stuart has written about Leukemia, B-Cell.
Robert Stuart
Connection Strength
0.093
Leukemia, B-Cell
  1. Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms. Clin Cancer Res. 2011 May 15; 17(10):3388-97.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.